SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
06-Sep-24 5:52 PM View: | Collegium Pharmaceutical, Inc (COLL) | 06-Sep-24 | Sale | 977 | $37.46 | $36,594.10 | (< 1%) 120.16K to 119.18K | |
06-Sep-24 5:52 PM View: | Collegium Pharmaceutical, Inc (COLL) | 05-Sep-24 | Private Sale | 19,248 | $38.30 | $737,198.00 | (14%) 139.41K to 120.16K | |
05-Jun-24 4:06 PM View: | Collegium Pharmaceutical, Inc (COLL) | 03-Jun-24 | Private Sale (Planned) | 25,000 | $32.57 | $814,180.00 | (15%) 164.41K to 139.41K | |
14-Feb-24 4:14 PM View: | Collegium Pharmaceutical, Inc (COLL) | 12-Feb-24 | Grant | 76,647 | -- | -- | 64% 119.52K to 196.16K | |
14-Feb-24 4:14 PM View: | Collegium Pharmaceutical, Inc (COLL) | 12-Feb-24 | Payment of Exercise | 31,756 | $33.70 | $1,070,180.00 | (16%) 196.16K to 164.41K | |
29-Nov-23 4:32 PM View: | Collegium Pharmaceutical, Inc (COLL) | 27-Nov-23 | Option Exercise | 25,600 | $15.90 | $407,040.00 | 21% 119.52K to 145.12K | |
29-Nov-23 4:32 PM View: | Collegium Pharmaceutical, Inc (COLL) | 27-Nov-23 | Planned Option Sale | 25,600 | $25.78 | $660,014.00 | (18%) 145.12K to 119.52K | |
28-Jun-23 4:08 PM View: | Collegium Pharmaceutical, Inc (COLL) | 26-Jun-23 | Private Sale (Planned) | 17,984 | $21.72 | $390,633.00 | (13%) 137.5K to 119.52K | |
14-Feb-23 5:18 PM View: | Collegium Pharmaceutical, Inc (COLL) | 13-Feb-23 | Sale (Planned) | 21,811 | $26.88 | $586,280.00 | (14%) 159.31K to 137.5K | |
14-Feb-23 5:18 PM View: | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-23 | Grant | 73,864 | -- | -- | 67% 109.5K to 183.36K | |
14-Feb-23 5:18 PM View: | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-23 | Payment of Exercise | 24,046 | $26.75 | $643,230.00 | (13%) 183.36K to 159.31K | |
16-Sep-22 4:22 PM View: | Collegium Pharmaceutical, Inc (COLL) | 15-Sep-22 | Market Sale (Planned) | 38,589 | $18.07 | $697,303.00 | (26%) 148.08K to 109.5K | (5%) |
15-Aug-22 4:34 PM View: | Collegium Pharmaceutical, Inc (COLL) | 11-Aug-22 | Market Sale (Planned) | 300 | $20.01 | $6,003.00 | (< 1%) 148.38K to 148.08K | 5% |
18-Mar-22 4:03 PM View: | Collegium Pharmaceutical, Inc (COLL) | 16-Mar-22 | Payment of Exercise | 734 | $18.99 | $13,938.70 | (< 1%) 149.12K to 148.38K | (< 1%) |
14-Feb-22 6:37 PM View: | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-22 | Grant | 71,041 | -- | -- | 80% 89.26K to 160.3K | |
14-Feb-22 6:37 PM View: | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-22 | Payment of Exercise | 11,179 | $17.63 | $197,086.00 | (7%) 160.3K to 149.12K | |
20-Sep-21 4:03 PM View: | Collegium Pharmaceutical, Inc (COLL) | 16-Sep-21 | Payment of Exercise | 734 | $19.67 | $14,437.80 | (< 1%) 89.99K to 89.26K | (< 1%) |
12-May-21 4:06 PM View: | Collegium Pharmaceutical, Inc (COLL) | 10-May-21 | Market Sale (Planned) | 7,000 | $22.77 | $159,390.00 | (7%) 96.99K to 89.99K | 3% |
18-Mar-21 4:07 PM View: | Collegium Pharmaceutical, Inc (COLL) | 16-Mar-21 | Payment of Exercise | 734 | $24.69 | $18,122.50 | (< 1%) 97.72K to 96.99K | (3%) |
12-Feb-21 4:16 PM View: | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-21 | Payment of Exercise | 5,858 | $25.95 | $152,015.00 | (6%) 103.58K to 97.72K | 3% |
21-Jan-21 4:29 PM View: | Collegium Pharmaceutical, Inc (COLL) | 20-Jan-21 | Market Sale (Planned) | 6,081 | $24.45 | $148,680.00 | (6%) 109.66K to 103.58K | |
21-Jan-21 4:29 PM View: | Collegium Pharmaceutical, Inc (COLL) | 19-Jan-21 | Grant | 52,132 | -- | -- | 91% 57.53K to 109.66K | |
16-Oct-20 4:07 PM View: | Collegium Pharmaceutical, Inc (COLL) | 15-Oct-20 | Market Sale (Planned) | 7,060 | $20.82 | $146,989.00 | (11%) 64.59K to 57.53K | 9% |
18-Sep-20 4:17 PM View: | Collegium Pharmaceutical, Inc (COLL) | 16-Sep-20 | Payment of Exercise | 734 | $19.33 | $14,188.20 | (1%) 65.33K to 64.59K | 2% |
18-Mar-20 4:16 PM View: | Collegium Pharmaceutical, Inc (COLL) | 16-Mar-20 | Payment of Exercise | 734 | $15.41 | $11,310.90 | (1%) 66.06K to 65.33K | (23%) |
12-Feb-20 4:25 PM View: | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-20 | Payment of Exercise | 2,085 | $21.62 | $45,077.70 | (3%) 68.14K to 66.06K | 13% |
07-Feb-20 4:11 PM View: | Collegium Pharmaceutical, Inc (COLL) | 05-Feb-20 | Grant | 24,750 | -- | -- | 57% 43.39K to 68.14K | |
18-Sep-19 4:06 PM View: | Collegium Pharmaceutical, Inc (COLL) | 16-Sep-19 | Payment of Exercise | 736 | $12.44 | $9,155.84 | (2%) 44.13K to 43.39K | (52%) |
19-Mar-19 5:41 PM View: | Collegium Pharmaceutical, Inc (COLL) | 15-Mar-19 | Payment of Exercise | 1,470 | $16.98 | $24,960.60 | (3%) 45.6K to 44.13K | (11%) |
29-Jan-19 4:37 PM View: | Collegium Pharmaceutical, Inc (COLL) | 25-Jan-19 | Grant | 25,600 | -- | -- | 128% 20.0K to 45.6K | |
05-Apr-18 5:00 PM View: | Collegium Pharmaceutical, Inc (COLL) | 04-Apr-18 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K |